| HOME >> MEDICINE >> TECHNOLOGY |
ImaginAb Joins Hand with GE Imanet for Developmental Drug
Research 64
Cancer Targeted Technology Inks Agreement with Bayer Pharma
for Cancer PET Imaging Agent 64
Lantheus Medical Imaging Wins Global Rights for Gadofosveset
Trisodium 64
Avid Radiopharmaceuticals Partners with Siemens PETNET
Solutions for Production of Florbetapir F 18 64
VisEn Expands Fluorescence Imaging Intellectual Patent
Portfolio through Acquisition of Bayer Schering's Portfolio 65
Cardinal Health Enters into Partnership with ProVision for
Cyclotrons 65
Center for Diagnostic Imaging Sets up New Imaging Center 65
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL
Biologics 65
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement
for Molybdenum-99 66
Lantheus Medical Imaging Purchases MS-325 Related Rights from
EPIX Pharmaceuticals 66
GE Healthcare Inks Agreement with Nycomed 66
Photocure Secures Reimbursement Approval for Hexvix in Germany 66
Agfa HealthCare to Acquire Insight Agents 67
Eckert & Ziegler Disinvests FCI Contrast Media Business 67
Guerbet Signs Distribution Agreement with Draximage for its
Nuclear Medicine Product Range 68
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL
Biologics 68
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement
for Molybdenum-99 68
Lantheus Medical Imaging Purchases MS-325 Related Rights for
Select Markets from EPIX Pharmaceuticals 69
MDS Nordion, TRIUMF and University of British Columbia Enter
into Partnership 69
Alseres Pharmaceuticals Signs Agreement for Special Protocol
Assessment of Altropane 69
Pharmalucence Wins Approval from FDA for Sestamibi Kit 70
Covidien Obtains Approval from Health Canada for Sestamibi
Injection 70
MD
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |